Top compounds associated with response to ESCO2


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC 0.17 0.001
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.16 0.001
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.1 0.002
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.1 0.002
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.11 0.002
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.1 0.002
Download CSV